Biomedical Engineering Reference
In-Depth Information
Pirollo,.K..F.,.Zon,.G.,.Rait,.A.,.Zhou,.Q.,.Yu,.W.,.Hogrefe,.R.,.and.Chang,.E..H..(2006).Tumor-targeting.
nanoimmunoliposome.complex.for.short.interfering.RNA.delivery..
Hum Gene Ther,
.17,.117-124.
Podesta,.J..E..and.Kostarelos,.K..(2009).Chapter.17—Engineering.cationic.liposome.siRNA.complexes.
for.in.vitro.and.in.vivo.delivery..
Methods Enzymol,
.464,.343-354.
Pozzi,.D.,.Caracciolo,.G.,.Caminiti,.R.,.De.Sanctis,.S..C.,.Amenitsch,.H.,.Marchini,.C.,.Montani,.M.,.
and.Amici,.A..(2009).Toward.the.rational.design.of.lipid.gene.vectors:.Shape.coupling.between.
lipoplex.and.anionic.cellular.lipids.controls.the.phase.evolution.of.lipoplexes.and.the.eficiency.
of.DNA.release..
ACS Appl Mater Interfaces,
.1,.2237-2249.
Qian,.Z..M.,.Li,.H.,.Sun,.H.,.and.Ho,.K..(2002).Targeted.drug.delivery.via.the.transferrin.receptor-
mediated.endocytosis.pathway..
Pharmacol Rev,
.54,.561-587.
Rayburn,. E.. R.. and. Zhang,. R.. (2008). Antisense,. RNAi,. and. gene. silencing. strategies. for. therapy:.
Mission.possible.or.impossible?.
Drug Discov Today,
.13,.513-521.
Robbins,.M.,.Judge,.A.,.Liang,.L.,.Mcclintock,.K.,.Yaworski,.E.,.and.Maclachlan,.I..(2007).2′-
O
-methyl-
modiied.RNAs.act.as.TLR7.antagonists..
Mol Ther,
.15,.1663-1669.
Robbins,.M.,.Judge,.A.,.and.Maclachlan,.I..(2009).siRNA.and.innate.immunity..
Oligonucleotides,
.19,.
89-102.
Romberg,.B.,.Hennink,.W..E.,.and.Storm,.G..(2008).Sheddable.coatings.for.long-circulating.nanopar-
ticles..
Pharm Res,
.25,.55-71.
Sahay,.G.,.Alakhova,.D..Y.,.and.Kabanov,.A..V..(2010).Endocytosis.of.nanomedicines..
J Control Release,
.
145,.182-195.
Semple,.S..C.,.Akinc,.A.,.Chen,.J.,.Sandhu,.A..P.,.Mui,.B..L.,.Cho,.C..K.,.Sah,.D..W..et.al..(2010).Rational.
design.of.cationic.lipids.for.siRNA.delivery..
Nat Biotechnol,
.28,.172-176.
Semple,.S..C.,.Klimuk,.S..K.,.Harasym,.T..O.,.Dos.Santos,.N.,.Ansell,.S..M.,.Wong,.K..F.,.Maurer,.N..
et.al..(2001).Eficient.encapsulation.of.antisense.oligonucleotides.in.lipid.vesicles.using.ioniz-
able. aminolipids:. Formation. of. novel. small. multilamellar. vesicle. structures..
Biochim Biophys
Acta,
.1510,.152-166.
Sioud,.M..(2008).Does.the.understanding.of.immune.activation.by.RNA.predict.the.design.of.safe.
siRNAs?.
Front Biosci,
.13,.4379-4392.
Soussan,.E.,.Cassel,.S.,.Blanzat,.M.,.and.Rico-Lattes,.I..(2009).Drug.delivery.by.soft.matter:.Matrix.and.
vesicular.carriers..
Angew Chem Int Ed Engl,
.48,.274-288.
Stanton,. M.. G.. and. Colletti,. S.. L.. (2010). Medicinal. chemistry. of. siRNA. delivery..
J Med Chem,
. 53,.
7887-7901.
Thierry,.A..R.,.Norris,.V.,.Molina,.F.,.and.Schmutz,.M..(2009).Lipoplex.nanostructures.reveal.a.general.
self-organization.of.nucleic.acids..
Biochim Biophys Acta,
.1790,.385-394.
Tseng,.Y..C.,.Mozumdar,.S.,.and.Huang,.L..(2009).Lipid-based.systemic.delivery.of.siRNA..
Adv Drug
Deliv Rev,
.61,.721-731.
Vaishnaw,.A..K.,.Gollob,.J.,.Gamba-Vitalo,.C.,.Hutabarat,.R.,.Sah,.D.,.Meyers,.R.,.De.Fougerolles,.T.,.
and.Maraganore,.J..(2010).A.status.report.on.RNAi.therapeutics..
Silence,
.1,.14.
Wagner,.R..W..(1994).Gene.inhibition.using.antisense.oligodeoxynucleotides..
Nature,
.372,.333-335.
Weisman,.S.,.Hirsch-Lerner,.D.,.Barenholz,.Y.,.and.Talmon,.Y..(2004).Nanostructure.of.cationic.lipid-
oligonucleotide.complexes..
Biophys J,
.87,.609-614.
Whitehead,. K.. A.,. Langer,. R.,. and. Anderson,. D.. G.. (2009). Knocking. down. barriers:. Advances. in.
siRNA.delivery..
Nat Rev Drug Discov,
.8,.129-138.
Wu,.Y.,.Ho,.Y..P.,.Mao,.Y.,.Wang,.X.,.Yu,.B.,.Leong,.K..W.,.and.Lee,.L..J..(2011).Uptake.and.intracellular.
fate. of. multifunctional. nanoparticles:. A. comparison. between. lipoplexes. and. polyplexes. via.
quantum.dot.mediated.Forster.resonance.energy.transfer..
Mol Pharm,
.8,.1662-1668.
Wu,.S..Y..and.Mcmillan,.N..A..(2009).Lipidic.systems.for.in.vivo.siRNA.delivery..
AAPS J,
.11,.639-652.
Wu,.Y.,.Yu,.B.,.Jackson,.A.,.Zha,.W.,.Lee,.L..J.,.and.Wyslouzil,.B..E..(2009).Coaxial.electrohydrodynamic.
spraying:.A.novel.one-step.technique.to.prepare.oligodeoxynucleotide.encapsulated.lipoplex.
nanoparticles..
Mol Pharm,
.6,.1371-1379.
Xu,. L.,. Huang,. C.. C.,. Huang,. W.,. Tang,. W.. H.,. Rait,. A.,. Yin,. Y.. Z.,. Cruz,. I.,. Xiang,. L.. M.,. Pirollo,.
K..F.,.and.Chang,.E..H..(2002).Systemic.tumor-targeted.gene.delivery.by.anti-transferrin.recep-
tor.scFv-immunoliposomes..
Mol Cancer Ther,
.1
,
.337-346.
